Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan 22:9:e52168.
doi: 10.7554/eLife.52168.

Single cell analysis reveals human cytomegalovirus drives latently infected cells towards an anergic-like monocyte state

Affiliations

Single cell analysis reveals human cytomegalovirus drives latently infected cells towards an anergic-like monocyte state

Miri Shnayder et al. Elife. .

Abstract

Human cytomegalovirus (HCMV) causes a lifelong infection through establishment of latency. Although reactivation from latency can cause life-threatening disease, our molecular understanding of HCMV latency is incomplete. Here we use single cell RNA-seq analysis to characterize latency in monocytes and hematopoietic stem and progenitor cells (HSPCs). In monocytes, we identify host cell surface markers that enable enrichment of latent cells harboring higher viral transcript levels, which can reactivate more efficiently, and are characterized by reduced intrinsic immune response that is important for viral gene expression. Significantly, in latent HSPCs, viral transcripts could be detected only in monocyte progenitors and were also associated with reduced immune-response. Overall, our work indicates that regardless of the developmental stage in which HCMV infects, HCMV drives hematopoietic cells towards a weaker immune-responsive monocyte state and that this anergic-like state is crucial for the virus ability to express its transcripts and to eventually reactivate.

Keywords: cytomegalovirus; hematopoietic stem and progenitor cells; herpesvirus; human; infectious disease; latency; microbiology; reactivation; single-cell RNA-seq.

Plain language summary

Most people around the world unknowingly carry the human cytomegalovirus, as this virus can become dormant after infection and hide in small numbers of blood stem cells (which give rise to blood and immune cells). Dormant viruses still make their host cells read their genetic information and create viral proteins – a process known as gene expression – but they do not use them to quickly multiply. However, it is possible for the cytomegalovirus to reawaken at a later stage and start replicating again, which can be fatal for people with weakened immune systems. It is therefore important to understand exactly how the virus can stay dormant, and how it reactivates. Only certain infected cells allow dormant viruses to later reactivate; in others, it never starts to multiply again. Techniques that can monitor individual cells are therefore needed to understand how the host cells and the viruses interact during dormant infection and reactivation. To investigate this, Shnayder et al. infected blood stem cells in the laboratory and used a method known as single-cell RNA analysis, which highlights all the genes (including viral genes) that are expressed in a cell. This showed that in certain cells, the virus dampens the cell defenses, leading to a higher rate of viral gene expression and, in turn, easier reactivation. Further experiments showed that the blood stem cells that expressed the viral genes were marked to become a type of immune cells known as monocytes. In turn, these infected monocytes were shown to be less able to defend the body against infection, suggesting that latent human cytomegalovirus suppresses the body’s innate immune response. The reactivation of human cytomegalovirus is a dangerous issue for patients who have just received an organ or blood stem cells transplant. The study by Shnayder et al. indicates that treatments that boost innate immunity may help to prevent the virus from reawakening, but more work is needed to test this theory.

PubMed Disclaimer

Conflict of interest statement

MS, AN, BR, BB, ML, NF, EP, SA, EB, DG, AA, BS, JS, NS, MS No competing interests declared

Figures

Figure 1.
Figure 1.. Cellular gene expression co-vary with viral transcript levels.
(A) t-SNE plot of 3416 latently infected CD14+ monocytes based on host and viral gene expression (Shnayder et al., 2018), colored by percentage of HCMV reads per cell. (B) Distribution of Z scores of the Spearman correlation coefficients between host transcript levels and total HCMV transcript levels across a single population of infected CD14+ monocytes. Black dots mark cells surface markers coding transcripts, blue marks CD74 and red marks transcripts of MHCII (isoforms HLA-RB1/HLA-DPB1/HLA-DRA/HLA-DQB1/HLA-DPA1/HLA-DQA1/HLA-DMA/HLA-DRB5/HLA-DQA2 and HLA-DMB, left to right), gray dots mark all other transcripts. (C and D) t-SNE plots of monocytes as presented in A colored coded by their expression levels of MHCII (HLA-RB1/HLA-DPB1/HLA-DRA/HLA-DQB1/HLA-DPA1/HLA-DQA1/HLA-DMA/HLA-DRB5/HLA-DQA2 and HLA-DMB) (C) or CD74 (D) transcripts. (E) Percentage of viral reads measured in all single cells by days post infection (dpi). Error bars represent standard deviation across the single cells.
Figure 1—figure supplement 1.
Figure 1—figure supplement 1.. High association between the correlation of host gene expression vs. viral gene expression and host gene expression vs. time post infection.
Scatterplot showing correlation of host transcript levels and total HCMV transcript levels compared to correlation of host transcript levels and time along infection.
Figure 1—figure supplement 2.
Figure 1—figure supplement 2.. CD74 and MHCII expression increases with culturing time of CD14+ monocytes.
Relative expression levels of CD74 (A) and MHCII (B) in HCMV- infected cells and uninfected cells, measured by RT-qPCR at 6hpi, 3dpi and 6dpi. Error bars reflect standard deviation of 3 measurements. A representative analysis of two independent experiments is shown.
Figure 2.
Figure 2.. CD74 and MHCII cell-surface levels in HCMV- infected monocytes inversely-correlate with viral transcript levels.
(A) HCMV- infected monocytes were FACS sorted according to cell-surface levels of CD74 or MHCII, at 3dpi. High and low gates were determined as highest and lowest 30% of the population, respectively. (B and C) Relative expression level of the viral transcripts RNA2.7 and UL138 (B) or MHCII and CD74 transcripts (C), as measured by RT-qPCR in HCMV- infected cells, sorted by either MHCII (left) or CD74 (right) cell-surface levels at 3dpi. (D) Relative abundance of viral DNA in HCMV- infected CD74high and CD74low monocytes, at 3dpi as measured by qPCR. Graphs show a representative experiment of 3 biological repeats, error bars reflect standard deviation of 3 measurements. P values as calculated by t-test are indicated.
Figure 2—figure supplement 1.
Figure 2—figure supplement 1.. CD74 and MHCII cell-surface levels in HCMV- infected monocytes inversely-correlate with viral transcript levels.
HCMV- infected monocytes were FACS sorted according to cell-surface levels of (A) MHCII or (B) CD74, at 3dpi. High and low gates were determined as highest and lowest 30% of the population, respectively. Two biological repeats are shown. Viral expression levels in cells from each gate were assessed by RT-qPCR measurement of the viral transcript RNA2.7. Error bars reflect standard deviation of 3 measurements. P values as calculated by t-test are indicated.
Figure 2—figure supplement 2.
Figure 2—figure supplement 2.. Cell-surface CD74 levels in HCMV- infected monocytes at 6dpi inversely-correlate with viral gene expression.
Expression level of viral transcripts RNA2.7 and UL138, as RT-qPCR measured in HCMV- infected cells, sorted by CD74 cell-surface levels at 6dpi. Error bars reflect standard deviation of 3 technical replicates. P values, as calculated by t-test, are indicated.
Figure 2—figure supplement 3.
Figure 2—figure supplement 3.. CD74 and MHCII genes are co-expressed in HCMV- infected monocytes.
Scatterplot showing read number of CD74 vs.read number of MHCII genes in single HCMV- infected monocytes according to scRNA-seq data (Shnayder et al., 2018).
Figure 2—figure supplement 4.
Figure 2—figure supplement 4.. Surface expression distribution of CD74 does not change in uninfected and infected cell populations.
Infected (green) and uninfected (gray) cells were stained for surface expression of CD74 and analyzed by flow cytometry at 0, 3 and 6dpi.
Figure 3.
Figure 3.. Changes in CD74 expression are induced by infection.
Uninfected primary monocytes were FACS sorted according to cell-surface levels of CD74. Equivalent numbers of CD74high and CD74low cells were infected with HCMV and differences in CD74 RNA levels and in viral DNA and RNA levels between these two cell populations were assessed by qPCR. (A) Relative CD74 transcript levels in CD74high and CD74low cells at 8hpi. (B) Relative abundance of viral DNA in CD74high and CD74low cells at 8hpi and 72hpi. (C) Relative expression level of the viral transcripts UL22A and RNA2.7 in CD74high and CD74low cells as measured at 8hpi and 72hpi. Graphs show a representative experiment of 3 biological repeats, error bars reflect standard deviation of 3 measurements. P values were calculated by t-test.
Figure 4.
Figure 4.. CD74low infected monocytes reactivate more efficiently.
HCMV- infected CD14+ Monocytes were sorted according to cell-surface levels of CD74 at 3dpi. Equivalent numbers of cells were plated and (A) differentiated into DCs followed by co-culture with fibroblasts to quantify reactivation events or (B) directly co-cultured with fibroblasts to induce reactivation. Data ais shown as number of infectious centers formed by CD74high vs. CD74low cells. Means and error bars (reflecting standard deviation) were generated from 4 independent experiments (A) and 3 independent experiments (B). Dot colors indicate sets from the same experiment. P values as calculated by t-test are indicated.
Figure 5.
Figure 5.. CD74 cell-surface levels allow enrichment of CD14+ monocytes carrying HCMV genomes from viremic patients.
CD14+ monocytes from HSCT recipients with HCMV reactivation were sorted according to CD74 cell-surface levels. In total, 4 samples were tested, originating from 3 different donors (samples 1 and 2 were collected at different time points from the same donor), and viral genome abundance was measured by ddPCR. (A) A representative FACS sort of the cells. The highest and lowest 30% of the population were collected as CD74high and CD74low samples. (B) ddPCR results of two representative replicates from a single sample, separated by yellow vertical line. Upper panel shows detection of viral DNA, lower panel reflects detection of host genomes. The magenta line marks the threshold. (C) Quantification of viral genomes in CD74high and CD74low cells from four different samples, presented as copies per 10,000 cells. Graph reflects mean and 95% CV of poisson distribution, calculated from 5 technical replicates for each donor. P values as calculated by Fisher test are indicated.
Figure 5—figure supplement 1.
Figure 5—figure supplement 1.. Sensitivity of viral genomes detection by ddPCR.
Standard curve measuring the sensitivity and accuracy of viral DNA detection by ddPCR, using a CMV positive control template in copy number of: 1, 3, 6, 14, 35 and 140. Detection was possible down to 3 copies per sample.
Figure 5—figure supplement 2.
Figure 5—figure supplement 2.. ddPCR analysis of natural samples.
(A) Analysis of samples from a healthy seropositive donor by ddPCR, done in eight replicates. Upper panel shows detection of viral DNA (1 positive event), lower panel reflects detection of host genomes. The magenta line marks the threshold. (B) Summary of all positive events detected in A. (C) Monocytes from 5 healthy seropositive individuals were FACS sorted according to B7H4 levels. A gate defining positive cells, as determined by minimal staining with isotype control (0.2%–0.8%) for each donor, and the sorting gates indicating the top 2% and bottom 70% are shown. (D) Quantification of viral genomes in the bottom 70% and top 2% B7H4 cells, designated as – and +, respectively, from 5 different donors, presented as copies per 10,000 cells. Graph reflects mean and 95% CV of poisson distribution, calculated from 2 to 4 technical replicates for each donor. (E) ddPCR analysis of monocytes from 7 samples originating from 6 HSCT patients with HCMV viremia. Each sample was tested in a duplicate for presence of viral genomes, shown separated by yellow vertical lines. Monocytes from donors that were positive for viral genomes by ddPCR (samples 1–4) were used for CD74 analysis, as shown in Figure 5.
Figure 6.
Figure 6.. HCMV latency in monocytes is associated with reduced immune-response gene signatures.
RNA-seq was performed on HCMV- infected CD14+ Monocytes that were sorted according to cell-surface levels of CD74 at 3dpi. (A) Normalized viral gene expression in CD74high and CD74low cells. P value, calculated using likelihood ratio test on logistic regression of viral reads, is indicated. (B) Summary of gene set enrichment analysis (GSEA) of differential expressed genes identified in RNA-seq analysis of CD74high and CD74low cells using annotated GO biological processes and Reactome pathways. (C) Representative pathways from GSEA of genes ranked by their differential expression between CD74high and CD74low cells. (D) tSNE plot of scRNA-seq of latent monocytes colored by expression level of the pathways shown in C. (E) Monocyte priming gene set from Velten et al. (2017) analyzed on GSEA. Genes are ranked by their differential expression between CD74high and CD74low monocytes. (F) tSNE plot of scRNA-seq of latent monocytes colored by the expression level of the monocyte priming gene set from Velten et al. (2017).
Figure 6—figure supplement 1.
Figure 6—figure supplement 1.. Viral gene expression profile of infected CD14+ monocytes correlates between CD74high and CD74low cells and to late lytic profile.
Scatterplot showing read number of all viral genes in CD74high compared with CD74low cells at 3dpi (A) Scatterplot showing read number of all viral genes in CD74high+CD74low cells at 3dpi compared to lytically infected monocyte-derived macrophages at 4dpi (B).
Figure 6—figure supplement 2.
Figure 6—figure supplement 2.. Comparison of changes detected in bulk RNA-seq and scRNA-seq data.
Relationship between the fold changes in RNA-seq of CD74high vs. CD74low infected monocytes and correlation with viral transcript levels in infected monocyte scRNA-seq. Only genes that were differentially expressed in the bulk RNA-seq with p values<0.01 are shown.
Figure 7.
Figure 7.. Inhibition of interferon signaling increases viral gene expression and promotes reactivation.
(A and B) HCMV- infected monocytes were treated at 3hpi with interferon signaling inhibitor, ruxolitinib (ruxo), or left untreated, and analyzed for gene expression level, by RNA-seq. (A) Expression of interferon-induced genes at 3dpi (left) and 6dpi (right). (B) Expression of viral genes at 3dpi (left) and 6dpi (right). (C) Viral gene expression in HCMV- infected monocytes that were treated with ruxo at 1, 2, 3dpi or left untreated was measured by RNA-seq at 5dpi. P values for (A-C), calculated using likelihood ratio test on logistic regression of viral reads, are indicated. (D) HCMV- infected monocytes were treated at 3hpi with interferon signaling inhibitor, ruxolitinib (ruxo), or left untreated, and at 6dpi, equivalent numbers of monocytes were co-cultured with fibroblasts to induce reactivation. Viral reactivation in ruxo treated vs. untreated cells was assessed by count of GFP positive plaques formed on the fibroblasts. Means and error bars (reflecting standard deviation) were calculated from 2 independent biological repeats. P value as calculated using likelihood ratio test on Poisson regression of positive plaque events is indicated.
Figure 7—figure supplement 1.
Figure 7—figure supplement 1.. Uniform induction of expression across viral genes by inhibition of interferon signaling.
Scatterplot showing read number of all viral genes in ruxolitinib treated cells compared to untreated cells at (A) 3dpi and (B) 6dpi.
Figure 8.
Figure 8.. Viral transcript levels in HCMV-infected CD34+ HSPCs is associated with priming towards the monocyte lineage and with reduced immune-response.
Pseudotime trajectory of single cell transcriptomes from HCMV- infected CD34+ HSPCs (n = 7,634, Shnayder et al., 2018) colored by pseudotime (A), viral transcript levels (B), expression of monocyte priming gene signature (Velten et al., 2017) (C) and CD14 expression (D). Zoom-in representation of the pseudotime trajectory in A-D, on the region exhibiting higher viral transcript level (top right group of cells), colored by expression of CD74 (E), viral transcript levels (F), expression level of the cellular response to interferon gamma pathways (G) and of the adaptive immune response pathway (H).
Author response image 1.
Author response image 1.

Similar articles

Cited by

References

    1. Avdic S, Cao JZ, McSharry BP, Clancy LE, Brown R, Steain M, Gottlieb DJ, Abendroth A, Slobedman B. Human Cytomegalovirus interleukin-10 polarizes monocytes toward a deactivated M2c phenotype to repress host immune responses. Journal of Virology. 2013;87:10273–10282. doi: 10.1128/JVI.00912-13. - DOI - PMC - PubMed
    1. Baca Jones CC, Kreklywich CN, Messaoudi I, Vomaske J, McCartney E, Orloff SL, Nelson JA, Streblow DN. Rat Cytomegalovirus infection depletes MHC II in bone marrow derived dendritic cells. Virology. 2009;388:78–90. doi: 10.1016/j.virol.2009.02.050. - DOI - PMC - PubMed
    1. Bergmann H. Business as usual: the p35 isoform of human CD74 retains function in antigen presentation. Immunology and Cell Biology. 2012;90:839–840. doi: 10.1038/icb.2012.51. - DOI - PubMed
    1. Blood Atlas 2019. VTCN1 the human protein atlas. The Human Protein Atlas. https://www.proteinatlas.org/ENSG00000134258-VTCN1/blood
    1. Chan G, Bivins-Smith ER, Smith MS, Smith PM, Yurochko AD. Transcriptome analysis reveals human Cytomegalovirus reprograms monocyte differentiation toward an M1 macrophage. The Journal of Immunology. 2008;181:698–711. doi: 10.4049/jimmunol.181.1.698. - DOI - PMC - PubMed

Publication types

Associated data